What percentage of fibromyalgia patients find relief with cannabis?

PostedFebruary 16, 2026

UpdatedFebruary 16, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Many individuals exploring options for fibromyalgia relief wonder just how common success really is. While research is ongoing, several studies and patient surveys provide insight into how effective cannabis may be in managing symptoms.

What data exists on relief rates

Reports from both clinical settings and patient communities suggest a significant number of people using cannabis report noticeable improvement in pain, sleep, and overall wellbeing.

Here’s a summary of what available evidence indicates about fibromyalgia relief with cannabis:

Self‑Reported Outcomes

In some surveys, over 50 percent of fibromyalgia patients reported significant pain and symptom reduction within a short period of cannabis use.

Continued Use Rates

A large proportion of users continue with cannabis treatment long-term, suggesting sustained effectiveness and tolerability.

Pain Relief Stats

While clinical trials provide mixed results, observational studies often show moderate pain relief stats, especially when cannabis is part of a personalised treatment plan.

Although exact figures vary depending on the study, it’s generally observed that around half of those trying cannabis for fibromyalgia relief report meaningful benefits. However, individual responses can differ based on strain, dosage, and method of use.

Always speak with a qualified healthcare professional before starting any new treatment. A well-informed approach ensures both safety and the best chance for improved quality of life.

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.